Cilostazol add-on therapy in patients with mild dementia receiving donepezil: a retrospective study.
<h4>Goal</h4>Combinatorial therapy directed at both vascular and neurodegenerative aspects of dementia may offer a promising strategy for treatment of dementia, which often has a multifactorial basis in the elderly. We investigated whether the phosphodiesterase III inhibitor cilostazol,...
Guardado en:
Autores principales: | Masafumi Ihara, Madoka Nishino, Akihiko Taguchi, Yumi Yamamoto, Yorito Hattori, Satoshi Saito, Yukako Takahashi, Masahiro Tsuji, Yukiko Kasahara, Yu Takata, Masahiro Okada |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c75ae3b23cee4040b68e76e235998f3d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A novel mouse model of ischemic carotid artery disease.
por: Yorito Hattori, et al.
Publicado: (2014) -
Clinically meaningful treatment responses after switching to galantamine and with addition of memantine in patients with Alzheimer&rsquo;s disease receiving donepezil
por: Kano O, et al.
Publicado: (2013) -
Model difference in the effect of cilostazol on the development of experimental pulmonary hypertension in rats
por: Toshikazu Ito, et al.
Publicado: (2021) -
Long-term cilostazol treatment reduces gliovascular damage and memory impairment in a mouse model of chronic cerebral hypoperfusion
por: Akihiro Kitamura, et al.
Publicado: (2017) -
Effect of cilostazol on arteriovenous fistula in hemodialysis patients
por: Jae Wan Jeon, et al.
Publicado: (2021)